GO
Loading...

Lightning Round: Solazyme, Allot Comm. & More

Friday, 4 Jan 2013 | 6:40 PM ET
Lightning Round
You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.

Are you ready skeedaddy? It's time for the Lightning Round. Cramer makes the call on viewer favorites.

Solazyme (SZYM): This stock is too speculative for me, said Cramer. There are just too many other places to put money to work that are better.


Allot Communications (ALLT): If you're long, I wouldn't sell, said Cramer. It's just too low here.

Teva Pharmaceuticals (TEVA): I'm a seller, said Cramer. I find this stock simply too hard to own.


Vasiliki Varvaki | E+ | Getty Images

Harvest Natural Resources (HNR): In this space I'd much rather put money in Chevron.

Energy Transfer Partners (ETP): My charitable trust owns this stock, admitted Cramer, but it's the worst stock.




Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com

  Price   Change %Change
SOLAZYME
---
ALLT
---
TEVA
---
HNR
---
ETP
---

Contact Mad Money

  • Showtimes

    Monday - Friday 6p ET
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.